Pharmacovigilance in Asia

Journal of Pharmacology and Pharmacotherapeutics

Volumn 4, Issue SUPPL.1, 2013, Pages

  Biswas, Pipasha ^a,b  

^a Symogen Limited   (United Kingdom)

^b ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

Author keywords

China; India; Japan; Korea; pharmacovigilance

Indexed keywords

GENERIC DRUG; PRESCRIPTION DRUG;

ASIA; BRUNEI DARUSSALAM; BUDGET; CAMBODIA; CHINA; CULTURAL FACTOR; DATA BASE; DRUG INDUSTRY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; GOVERNMENT; INDIA; INDONESIA; INFECTION; INFORMATION DISSEMINATION; INFORMATION PROCESSING; JAPAN; LAOS; LAW; MALAYSIA; MANDATORY REPORTING; MYANMAR; ORGANIZATIONAL STRUCTURE; PHILIPPINES; POSTMARKETING SURVEILLANCE; REVIEW; SINGAPORE; SOUTH KOREA; THAILAND; VIET NAM; VOLUNTARY REPORTING;

EID: 84889593396     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.120941     Document Type: Review

References (18)

1. Healthcare Reform in China. IMS Health Intelligence. Available from: http://www.imshealthasia.com. [Last accessed on 2013 August 20].
2. Wang Y, Xu HM, Li M, Guo Y, Yu BY, Zeng FD. Regional pharmacovigilance practice in China. Int J Risk Saf Med 2008;20:51-6.
3. China's Pharmacovigilance System: The Hunger For Safety Insights. Sara Gambrill. Lifescience Leader. http://www.dav.gov.vn/[Last accessed on 2013 August 20].
4. Kulkarni RD. Reporting system for rare side effects of non-narcotic analgesics in India: Problems and opportunities. Med Toxicol 1986;1:110-3.
5. Protocol for National Pharmacovigilance Program. CDSCO, Ministry of Health and Family Welfare, Government of India. November, 2004.
6. Setting Standards for Proactive Pharmacovigilance in India: The Way Forward. P. Biswas, A. K. Biswas. Indian J Pharmacol 2007;39:124-8.
7. Pharmacovigilance Programme for India (PvPI): Assuring Drug Safety. CDSCO, Directorate General of Health Services, Ministry of Health and Family Welfare. Available from: http://cdsco.nic.in/pharmacovigilance.htm. [Last accessed on 2013 August 20].
8. Central Drugs Standard Control Organisation. Schedule Y (Amended version) 2005. Available from: http://cdsconicin/html/GCP1html. [Last accessed on 2013 August 20].
9. The Japanese Generic Drug Market: Opportunities and Strategies for Success. Thomson Reuters. Available from: http://thomsonreuters.com/business- unit/science/pdf/ls/newport-japanese-generics.pdf. [Last accessed on 2013 August 20].
10. Pharmacovigilance activities in Japan. Available from: http://www.pmda.go.jp/regulatory/file/english-presentation/safety/S-E2hori.pdf. [Last accessed on 2013 August 20].
11. Current Status and New Directions for Pharmacovigilance in Korea. Available from: http://www.apec-ahc.org/../Joungwon-Oh-28-April-Plenary-Session- 1030a DIA 2011. [Last accessed on 2013 August 20].
12. Regional Pharmacovigilance System in Korea. Available from: http://www. drugsafe.or.kr/iwt/ds/en/community/EgovCenterGuide.do [Last accessed on 2013 August 20].
13. Pharmacovigilance system and its implimentation in Indonesia. Dra. RATNA IRAWATI, Apt., M.Kes. Available from: http://www.pmda.go.jp/.. indonesian../5-Bu-Ratna-Revised-12-Feb-13-Pres [Last accessed on 2013 August 20].
14. Adverse drug reactions occurring within Malaysia-BPFK. Available from: http://www.portal.bpfk.gov.my. [Last accessed on 2013 August 20].
15. Hartigan-Go K. Developing a pharmacovigilance system in the Philippines, a country of diverse culture and strong traditional medicine background. Toxicology 2002;181-182:103-7.
16. Pharmacovigilance system in Singapore. Available from: http://www.hsa. gov sg. [Last accessed on 2013 August 20].
17. Pharmacovigilance system in Thailand. Available from: http://thaipvc.fda. moph.go.th/thaihvc/index.jsf. [Last accessed on 2013 August 20].
18. Pharmacovigilance system in Vietnam. The National centre for Drug Information and Adverse Drug Reaction Monitoring, Vietnam. http://www. dav.gov.vn/[Last accessed on 2013 August 20].